Thalidomide-Dexamethasone vs Interferon-α-Dexamethasone as maintenance treatment after ThaDD induction for multiple myeloma (MM):: Final analysis of a prospective, randomized study.

被引：0
|
作者：
Polloni, Claudia [1 ]
Corvatta, Laura [1 ]
Piersantelli, Maria-Novella [1 ]
Galieni, Piero [2 ]
Visani, Giuseppe [3 ]
Alesiani, Francesco [4 ]
Catarini, Massimo [5 ]
Brunori, Marino [6 ]
Burattini, Maurizio [7 ]
Centurioni, Riccardo [8 ]
Ferranti, Mario [9 ]
Giuliodori, Luciano [10 ]
Candela, Marco [11 ]
Mele, Anna [12 ]
Marconi, Monica [1 ]
Leoni, Pietro [1 ]
机构：
[1] Univ Osped Riuniti, Azienda Osped, Ancona, Italy
[2] Osped Ascoli Piceno, Div Ematol, Ascoli Piceno, Italy
[3] Osped Pesaro, Div Ematol, Pesaro, Italy
[4] Osped San Severino, Unit Oncoematol, Marche, Italy
[5] Osped Macerata, Div Ematol, Macerata, Italy
[6] Osped Fano, Div Ematol, Fano, Italy
[7] Osped Jesi, Div Med, Jesi, Italy
[8] Osped Civitanova Marche, Div Med, Civitanova Marche, Italy
[9] Osped Tolentino, Div Med, Tolentino, Italy
[10] Osped Fabriano, Oncol Sect, Fabriano, Italy
[11] Osped Fabriano, Div Med, Fabriano, Italy
[12] Osped Tricase, Div Ematol, Tricase, Italy
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
532
引用
收藏
页码：164A / 164A
页数：1
相关论文
共 50 条
  • [1] Thalidomide-dexamethasone (Thal-dex) vs interferon-a-dexamethasone (IFN-dex) as maintenance treatment after ThaDD induction for multiple myeloma (MM): First analysis of a prospective randomized study.
    Offidani, Massimo
    Corvatta, Laura
    Polloni, Claudia
    Piersantelli, Maria-Novella
    Galieni, Piero
    Visani, Giuseppe
    Alesiani, Francesco
    Catarini, Massimo
    Brunori, Marino
    Burattini, Maurizio
    Centurioni, Riccardo
    Ferranti, Mario
    Giuliodori, Luciano
    Candela, Marco
    Marconi, Monica
    Leoni, Pietro
    [J]. BLOOD, 2006, 108 (11) : 1018A - 1018A
  • [2] Thalidomide-dexamethasone versus Interferon-alpha-dexamethasone as maintenance treatment after ThaDD induction for multiple myeloma: a prospective, multicentre, randomised study
    Offidani, Massimo
    Corvatta, Laura
    Polloni, Claudia
    Piersantelli, Maria-Novella
    Gentili, Silvia
    Galieni, Piero
    Visani, Giuseppe
    Alesiani, Francesco
    Catarini, Massimo
    Brunori, Marino
    Samori, Arduino
    Burattini, Maurizio
    Centurioni, Riccardo
    Ferranti, Mario
    Giuliodori, Luciano
    Candela, Marco
    Mele, Anna
    Marconi, Monica
    Leoni, Pietro
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2009, 144 (05) : 653 - 659
  • [3] Thalidomide-dexamethasone plus pegylated liposomal doxorubicin vs. thalidomide-dexamethasone: a case-matched study in advanced multiple myeloma
    Offidani, Massimo
    Bringhen, Sara
    Corvatta, Laura
    Falco, Patrizia
    Marconi, Monica
    Avonto, Ilaria
    Piersantelli, Maria-Novella
    Polloni, Claudia
    Boccadoro, Mario
    Leoni, Pietro
    Palumbo, Antonio
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2007, 78 (04) : 297 - 302
  • [4] Bortezomib(Velcade®)-Thalidomide-Dexamethasone (VTD) Is Superior to Thalidomide-Dexamethasone (TD) In Patients with Multiple Myeloma (MM) Progressing or Relapsing After Autologous Transplantation.
    Garderet, Laurent
    Iacobelli, Simona
    Moreau, Philippe
    Dib, Mamoun
    Caillot, Denis
    Niederwieser, Dietger W.
    Masszi, Tamas
    Fontan, Jean
    Michallet, Mauricette
    Gratwohl, Alois
    Milone, Giuseppe
    Doyen, Chantal
    Pegourie, Brigitte
    Hajek, Roman
    Casassus, Philippe
    Kolb, Brigitte
    Chaleteix, Carine
    Hertenstein, Bernd
    Onida, Francesco
    Ludwig, Heinz
    Vekemans, Marie Christiane
    Ketterer, Nicolas
    Daguenel, Anne
    Gorin, Norbert C.
    Harousseau, Jean Luc
    de Witte, Theo
    Morris, Curly
    Gahrton, Gosta
    [J]. BLOOD, 2010, 116 (21) : 1254 - 1254
  • [5] Thalidomide-Dexamethasone vs. Melphalan-Prednisone as first line treatment and Thalidomide-Interferon vs. interferon maintenance therapy in elderly patients with multiple myeloma.
    Ludwig, Heinz
    Tothova, Elena
    Hajek, Roman
    Drach, Johannes
    Adam, Zdenek
    Labar, Boris
    Egyed, Miklos
    Spicka, Ivan
    Gisslinger, Heinz
    Kuhn, Ingrid
    Hinke, Axel
    [J]. BLOOD, 2007, 110 (11) : 163A - 163A
  • [6] Bortezomib (BOR)-Thalidomide-Dexamethasone (VTD) as induction treatment for newly diagnosed Multiple Myeloma (MM) is associated with a lower rate of Second Primary Malignancies (SPMs) compared to Thalidomide-Dexamethasone (TD)
    Brioli, A.
    Pezzi, A.
    Muegge, L-O
    Derudas, D.
    Petti, M. C.
    Zannetti, B. A.
    Ferrara, F.
    Rocchi, S.
    Nobile, F.
    Baraldi, A.
    Musto, P.
    Lanza, F.
    Mancuso, K.
    Canepa, L.
    Catalano, L.
    Lazzaro, A.
    Pinotti, G.
    Boccadoro, M.
    Hochhaus, A.
    Cavo, M.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 69 - 69
  • [7] Randomized trial of α-interferon or dexamethasone as maintenance treatment for multiple myeloma
    Alexanian, R
    Weber, D
    Dimopoulos, M
    Delasalle, K
    Smith, TL
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2000, 65 (03) : 204 - 209
  • [8] Bortezomib (velcade(R))-thalidomide-dexamethasone (VTD) vs thalidomide-dexamethasone (TD) in preparation for autologous stem-cell (SC) transplantation (ASCT) in newly diagnosed multiple myeloma (MM)
    Cavo, Michele
    Patriarca, Francesca
    Tacchetti, Paola
    Galli, Monica
    Perrone, Giulia
    Petrucci, Maria Teresa
    Brioli, Annamaria
    Bringhen, Sara
    Pantani, Lucia
    Tosi, Patrizia
    Crippa, Claudia
    Zamagni, Elena
    Di Raimondo, Francesco
    Narni, Franco
    Cellini, Claudia
    Ceecolini, Michela
    Pescosta, Norbert
    Goldaniga, Maria Cecilia
    Montefusco, Vittorio
    Callea, Vincenzo
    De Stefano, Valerio
    Caravita, Tommaso
    Boccadoro, Mario
    Baccarani, Michele
    [J]. BLOOD, 2007, 110 (11) : 30A - 30A
  • [9] Bortezomib-Thalidomide-Dexamethasone Compared with Thalidomide-Dexamethasone as Induction and Consolidation Therapy Before and After Double Autologous Transplantation In Newly Diagnosed Multiple Myeloma: Results From a Randomized Phase 3 Study
    Cavo, Michele
    Perrone, Giulia
    Buttignol, Silvia
    Calabrese, Elisabetta
    Galli, Monica
    Bringhen, Sara
    Spadano, Tonino
    Baldini, Luca
    Caravita, Tommaso
    Nozzoli, Chiara
    Brioli, Annamaria
    Masini, Luciano
    Furlan, Anna
    Pantani, Lucia
    Derudas, Daniele
    Ballanti, Stelvio
    Pisani, Francesco
    De Stefano, Valerio
    Catania, Gioacchino
    Castagna, Luca
    Ferrara, Felicetto
    Callea, Vincenzo
    Musto, Pellegrino
    Zamagni, Elena
    Baccarani, Michele
    [J]. BLOOD, 2010, 116 (21) : 25 - 25
  • [10] Bortezomib (Velcade®)-Thalidomide-Dexamethasone (VTD) vs Thalidomide-Dexamethasone to treat multiple myeloma patients progressing or relapsing after autologous transplantation:: the MMVAR trial, a study from the myeloma subcommittee of the Chronic Leukemia Working Party of the EBMT
    Garderet, L.
    Iacobelli, S.
    Moreau, P.
    Onida, F.
    Koenecke, C.
    Pabst, T.
    Doyen, C.
    Crawley, C.
    Hajek, R.
    Linkesch, W.
    Harousseau, J. -L.
    Michallet, M.
    Doran, Z.
    de Witte, T.
    Niederwieser, D.
    Gahrton, G.
    Morris, C.
    [J]. BONE MARROW TRANSPLANTATION, 2008, 41 : S36 - S36
12345